Business Wire
BusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex Times
Back to front
Park Ha Biological applies for Personal Care Products Council membership as it targets Amazon North America expansion
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jul 1, 8:16 AM EDT

Park Ha Biological applies for Personal Care Products Council membership as it targets Amazon North America expansion

The Chinese personal care ingredient maker says it has filed a complete membership application with the Personal Care Products Council (PCPC), framing the step as a way to align its brand with international standards.

Park Ha Biological Technology Co., Ltd. said it has formally filed a complete membership application to the Personal Care Products Council (PCPC), a move the company described as a strategic milestone in its broader expansion into Amazon North America.

In a statement posted July 1, Park Ha Biological said the application is intended to help the brand align with international standards for personal care products, and to strengthen its positioning with buyers and partners in regulated or standards-driven markets.

The company tied the timing of the PCPC move to its planned commercial push through Amazon North America. Park Ha Biological did not disclose additional details in the announcement about the products it will prioritize on the platform or the timeline for any listing or rollout.

Park Ha Biological is listed in the United States under the ticker BYAH. The company’s expansion messaging suggests it is aiming to improve credibility and market readiness for the U.S. personal care channel, where industry associations often serve as indicates of compliance, manufacturing expectations, and product governance.

PCPC membership is typically associated with an organization’s participation in an industry framework for personal care products. Park Ha Biological did not specify which internal processes or documentation it believes were most relevant to its application, other than stating that it filed a “complete” membership package.

The step comes as many consumer and health-adjacent brands increasingly treat marketplace access and standards alignment as part of go-to-market planning, particularly for categories that face heightened scrutiny over sourcing, labeling, and product stewardship. By referencing international standards and an American industry group, Park Ha Biological appears to be emphasizing that it can meet the expectations of U.S. distribution channels.

What Park Ha Biological did not provide in the July 1 announcement includes any update on whether PCPC has accepted the application, whether membership would be conditional, or when a decision is expected. It also did not outline any near-term financial impact, costs, or changes to its guidance tied to the application.

Investors and business partners may want to watch for follow-on updates from Park Ha Biological regarding the status of the PCPC review, any changes to how its products are presented for Amazon customers, and whether the company provides further detail on its North America expansion plan in future filings or communications.

Why It Matters

  • Industry association membership can function as a credibility announcement for brands entering standards-focused consumer markets, particularly in personal care.
  • A marketplace-focused expansion into Amazon North America suggests Park Ha Biological is working to reduce friction with U.S. distribution expectations.
  • The PCPC application status could become a gating item for future partnerships, marketing, or product positioning in the U.S.
  • Because the company did not tie the application to financial metrics, near-term performance impact is uncertain and likely depends on subsequent approvals and commercialization progress.

Sources

Key Facts

  • Park Ha Biological Technology Co., Ltd. said it filed a complete membership application with the Personal Care Products Council (PCPC) on July 1, 2026.
  • The company framed the PCPC step as aligning the brand with international standards for personal care products.
  • Park Ha Biological said the move marks a strategic milestone in its expansion into Amazon North America.
  • The company did not disclose acceptance status, review timeline, or decision outcome in the July 1 announcement.
  • Park Ha Biological is listed on NASDAQ under ticker BYAH.
  • The statement did not provide product-specific or commercial rollout details for Amazon North America.

Technology Related

Oct 23, 8:59 PM EDT
The Apex Times

Amazon shares among AI-infrastructure selloff targets as mega-cap tech resets

A broad pullback in AI infrastructure-linked equities has hit even companies whose financial results and demand indicators were described as holding up, according to a market-focused report. Amazon was cited alongside other large technology names as investors reassess near-term spending and competitive momentum.

Amazon shares among AI-infrastructure selloff targets as mega-cap tech resets
The Apex Times